Invasive aspergillosis in critically ill patients without malignancy

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 6, 2004, Pages 621-625

  Meersseman, Wouter ^a   Vandecasteele, Stefaan J ^b   Wilmer, Alexander ^b   Verbeken, Eric ^b   Peetermans, Willy E ^b   Van Wijngaerdert, Eric ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

Aspergillosis; Critically ill; Mortality

Indexed keywords

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; AUTOPSY; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE PREDISPOSITION; FEMALE; FUNGUS HYPHAE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION RISK; INTENSIVE CARE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; ASPERGILLOSIS; BELGIUM; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 4444302605     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200401-093OC     Document Type: Article

References (24)

1. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000;30:696-709.
2. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. the spectrum of the disease in 98 patients. Medicine (Baltimore) 1970;49:147-173.
3. Ascioglu S, Rex JH, de Pauw B. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
4. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:1604-1610.
5. Gotway MB, Dawn SK, Caoili EM, Reddy GP, Araoz PA, Webb WR. The radiologie spectrum of pulmonary Aspergillus infections. J Comput Assist Tomogr 2002;26:159-173.
6. Herbrecht R, Denning DW, Patterson TF. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.
7. Denning DW. Echinocandin antifungal drugs. Lancet 2003;362:1142-1151.
8. Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrard PA, Glupczynski Y, Installe EJ. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001;27:59-67.
9. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998;26:1473-1475.
10. Petri MG, Konig J, Moecke HP. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997;23:317-325.
11. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003;15:71-75.
12. Meersseman W, Vandecasteele SJ, Van Wijngaerden E, Maertens J, Wilmer A, Peetermans WE. Invasive aspergillosis: an emerging pathogen in non-hemato-oncological patients [abstract]. 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, May 1-4, 2004.
13. Anaissie EJ, Stratton SL, Dignani MC, Summerbell RC, Rex JH, Monson TP, Spencer T, Kasai M, Francesconi A, Walsh TJ. Pathogenetic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002;34:780-789.
14. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003;349:2366-2367.
15. Greene RE, Schlamm HT, Stark P, The Global Aspergillus Study Group and The Invasive Fungal Infection Group of the EORTC. Radiologic findings in acute invasive pulmonary aspergillosis: utility and reliability of halo sign and air-crescent sign for diagnosis and treatment of IPA in high-risk patients [abstract]. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, May 10-13, 2003.
16. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change and review. Clin Infect Dis 2003;37:S265-S280.
17. Brown MJ, Worthy SA, Flint JDA, Müller NL. Invasive aspergillosis in the immunocompromised host: utility of computed tomography and bronchoalveolar lavage. Clin Radiol 1998;53:255-257.
18. Burton EC, Nemetz PN. Medical error and outcome measures: where have all the autopsies gone? Medscape General Medicine 2000; 2000:E8.
19. Roosen J, Frans E, Wilmer A, Knockaert DC, Bobbaers H. Comparison of post-mortem clinical diagnoses in critically ill patients and subsequent autopsy findings. Mayo Clin Proc 2000;75:562-567.
20. Denning DW, Marinus A, Cohen J. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998;37:173-180.
21. Annane D, Sebille V, Charpentier C. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871.
22. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003;362:1828-1838.
23. Palmer LB, Greenberg HB, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991;46:15-20.
24. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999;78:123-138.